BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17710732)

  • 1. The pleiotropic effects of excessive luteinizing hormone secretion in transgenic mice.
    Sutton AL; Keri RA
    Semin Reprod Med; 2007 Sep; 25(5):360-7. PubMed ID: 17710732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The permissive role of prolactin as a regulator of luteinizing hormone action in the female mouse ovary and extragonadal tumorigenesis.
    Bachelot A; Carré N; Mialon O; Matelot M; Servel N; Monget P; Ahtiainen P; Huhtaniemi I; Binart N
    Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E845-52. PubMed ID: 23921141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What have gonadotrophin overexpressing transgenic mice taught us about gonadal function?
    Rulli SB; Huhtaniemi I
    Reproduction; 2005 Sep; 130(3):283-91. PubMed ID: 16123235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically modified mouse models addressing gonadotropin function.
    Ratner LD; Rulli SB; Huhtaniemi IT
    Reprod Biol; 2014 Mar; 14(1):9-15. PubMed ID: 24607250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequences of elevated luteinizing hormone on diverse physiological systems: use of the LHbetaCTP transgenic mouse as a model of ovarian hyperstimulation-induced pathophysiology.
    Mann RJ; Keri RA; Nilson JH
    Recent Prog Horm Res; 2003; 58():343-75. PubMed ID: 12795427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors.
    Risma KA; Clay CM; Nett TM; Wagner T; Yun J; Nilson JH
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1322-6. PubMed ID: 7877975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin secretion, synthesis, and gene expression in human growth hormone transgenic mice and in Ames dwarf mice.
    Tang K; Bartke A; Gardiner CS; Wagner TE; Yun JS
    Endocrinology; 1993 Jun; 132(6):2518-24. PubMed ID: 8504754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproductive abnormalities in human IGF binding protein-1 transgenic female mice.
    Froment P; Seurin D; Hembert S; Levine JE; Pisselet C; Monniaux D; Binoux M; Monget P
    Endocrinology; 2002 May; 143(5):1801-8. PubMed ID: 11956162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models for aberrations of gonadotropin action.
    Peltoketo H; Zhang FP; Rulli SB
    Rev Endocr Metab Disord; 2011 Dec; 12(4):245-58. PubMed ID: 21484328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian hyperstimulation by LH leads to mammary gland hyperplasia and cancer predisposition in transgenic mice.
    Milliken EL; Ameduri RK; Landis MD; Behrooz A; Abdul-Karim FW; Keri RA
    Endocrinology; 2002 Sep; 143(9):3671-80. PubMed ID: 12193583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic hypersecretion of luteinizing hormone in transgenic mice disrupts both ovarian and pituitary function, with some effects modified by the genetic background.
    Nilson JH; Abbud RA; Keri RA; Quirk CC
    Recent Prog Horm Res; 2000; 55():69-89; discussion 89-91. PubMed ID: 11036934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luteinizing hormone and human chorionic gonadotropin: origins of difference.
    Choi J; Smitz J
    Mol Cell Endocrinol; 2014 Mar; 383(1-2):203-13. PubMed ID: 24365330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of the polycystic ovarian phenotype and characterization of ovulatory capacity in the estrogen receptor-alpha knockout mouse.
    Couse JF; Bunch DO; Lindzey J; Schomberg DW; Korach KS
    Endocrinology; 1999 Dec; 140(12):5855-65. PubMed ID: 10579351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nongonadal LH receptors, their involvement in female reproductive function and a new applicable approach.
    Ziecik AJ; Bodek G; Blitek A; Kaczmarek M; Waclawik A
    Vet J; 2005 Jan; 169(1):75-84. PubMed ID: 15683766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-alpha-subunit promoter/Simian virus 40 T-antigen fusion gene.
    Mikola M; Kero J; Nilson JH; Keri RA; Poutanen M; Huhtaniemi I
    Oncogene; 2003 May; 22(21):3269-78. PubMed ID: 12761497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex.
    Kero J; Poutanen M; Zhang FP; Rahman N; McNicol AM; Nilson JH; Keri RA; Huhtaniemi IT
    J Clin Invest; 2000 Mar; 105(5):633-41. PubMed ID: 10712435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse models of altered gonadotrophin action: insight into male reproductive disorders.
    Jonas KC; Oduwole OO; Peltoketo H; Rulli SB; Huhtaniemi IT
    Reproduction; 2014 Oct; 148(4):R63-70. PubMed ID: 25030890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of human chorionic gonadotropin causes multiple reproductive defects in transgenic mice.
    Matzuk MM; DeMayo FJ; Hadsell LA; Kumar TR
    Biol Reprod; 2003 Jul; 69(1):338-46. PubMed ID: 12672665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin, steroid, and thyroid hormone milieu of young SWR mice bearing spontaneous granulosa cell tumors.
    Beamer WG
    J Natl Cancer Inst; 1986 Nov; 77(5):1117-23. PubMed ID: 3095581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of diethylstilbestrol on luteinizing hormone-producing cells in the mouse anterior pituitary.
    Ishikawa M; Murai E; Hashiguchi Y; Iguchi T; Sato T
    Exp Biol Med (Maywood); 2014 Mar; 239(3):311-9. PubMed ID: 24521563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.